Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunlin Jin

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Bioscience Trends|September 15, 2017
New medical education reform in China: Towards healthy China 2030Peipei Song, Chunlin Jin, Wei Tang
Bioscience Trends|October 27, 2017
Price adjustment for traditional Chinese medicine procedures: Based on a standardized value parity modelHaiyin Wang, Chunlin Jin, Qingwu Jiang
Intractable & Rare Diseases Research|December 4, 2025
AI-driven enhancements in rare disease diagnosis and support system optimizationXin Wang, Da He, Chunlin Jin
Sensors (Basel, Switzerland)|April 5, 2016
SACRB-MAC: A High-Capacity MAC Protocol for Cognitive Radio Sensor Networks in Smart GridZhutian Yang, Zhenguo Shi, Chunlin Jin
Intractable & Rare Diseases Research|September 17, 2019
Focusing on basic data and a model of healthcare security for rare diseases: The Multidisciplinary Expert Seminar on Healthcare Security for Rare Diseases in China was held in BeijingQi Kang, Chunlin Jin, Dingguo Li
Bioscience Trends|June 19, 2022
Needs of cancer patients during the SARS-CoV-2 Omicron lockdown: A population-based survey in Shanghai, ChinaMinxing Chen, Ruijia Li, Gang Ding, et al.
Intractable & Rare Diseases Research|March 31, 2017
Innovative measures to combat rare diseases in China: The national rare diseases registry system, larger-scale clinical cohort studies, and studies in combination with precision medicine researchPeipei Song, Jiangjiang He, Fen Li, et al.
Intractable & Rare Diseases Research|June 5, 2018
China has officially released its first national list of rare diseasesJiangjiang He, Qi Kang, Jiahao Hu, et al.
Global Health & Medicine|December 17, 2020
Improved treatment capacity and quality of care: the effectiveness of the stroke prevention and treatment system in Shanghai, China from 2012-2017Bifan Zhu, Duo Chen, Chunlin Jin, et al.
Frontiers in Pharmacology|February 6, 2025
Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modellingQian Xing, Wendi Cheng, Wei Wang, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Bioscience Trends|September 15, 2017
New medical education reform in China: Towards healthy China 2030Peipei Song, Chunlin Jin, Wei Tang
Bioscience Trends|October 27, 2017
Price adjustment for traditional Chinese medicine procedures: Based on a standardized value parity modelHaiyin Wang, Chunlin Jin, Qingwu Jiang
Intractable & Rare Diseases Research|December 4, 2025
AI-driven enhancements in rare disease diagnosis and support system optimizationXin Wang, Da He, Chunlin Jin
Sensors (Basel, Switzerland)|April 5, 2016
SACRB-MAC: A High-Capacity MAC Protocol for Cognitive Radio Sensor Networks in Smart GridZhutian Yang, Zhenguo Shi, Chunlin Jin
Intractable & Rare Diseases Research|September 17, 2019
Focusing on basic data and a model of healthcare security for rare diseases: The Multidisciplinary Expert Seminar on Healthcare Security for Rare Diseases in China was held in BeijingQi Kang, Chunlin Jin, Dingguo Li
Bioscience Trends|June 19, 2022
Needs of cancer patients during the SARS-CoV-2 Omicron lockdown: A population-based survey in Shanghai, ChinaMinxing Chen, Ruijia Li, Gang Ding, et al.
Intractable & Rare Diseases Research|March 31, 2017
Innovative measures to combat rare diseases in China: The national rare diseases registry system, larger-scale clinical cohort studies, and studies in combination with precision medicine researchPeipei Song, Jiangjiang He, Fen Li, et al.
Intractable & Rare Diseases Research|June 5, 2018
China has officially released its first national list of rare diseasesJiangjiang He, Qi Kang, Jiahao Hu, et al.
Global Health & Medicine|December 17, 2020
Improved treatment capacity and quality of care: the effectiveness of the stroke prevention and treatment system in Shanghai, China from 2012-2017Bifan Zhu, Duo Chen, Chunlin Jin, et al.
Frontiers in Pharmacology|February 6, 2025
Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modellingQian Xing, Wendi Cheng, Wei Wang, et al.
Pageof 7